Inhaled hydrogen gas therapy for the prevention of lung transplant-induced ischemia-reperfusion injury
Project/Area Number |
25893118
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Respiratory surgery
|
Research Institution | Osaka University |
Principal Investigator |
TOMOHIRO Kawamura 大阪大学, 医学(系)研究科(研究院), 助教 (30528675)
|
Project Period (FY) |
2013-08-30 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 移植・再生医療 / 水素 / 肺移植 / 外科 / 酸化ストレス |
Outline of Final Research Achievements |
Our basic data have shown that hydrogen is a high potential therapeutic gas for the lung transplant-induced ischemia-reperfusion injury. To introduce the hydrogen gas therapy to clinical practice, we developed the ventilation system with hydrogen. And we have started to administer hydrogen gas to the patient. On the other hand, to elucidate the mechanism of the therapeutic effect of hydrogen gas, we also set up the cell experiment system with hydrogen.
|
Report
(3 results)
Research Products
(4 results)